Fertility doctors Reproductive Associates of Delaware (RAD) is alarmed about the rising tide of failed in vitro fertilization (IVF) treatments that come in throughout the U.S. and the world, and recommend further analysis of a study of patients who do not follow IVF or IVF is unnecessary. They started a new pilot program called the game failed IVF, probation.

“IVF is an important and effective treatment for those who really need,” said Ronald F. Feinberg MD, PhD, a reproductive endocrinologist who has directed RAD IVF program since 1997. “But many women are not IVF, or perhaps not even need IVF, the underlying disease is not identified or treated well.”

some common diseases may block embryo implantation and pregnancy hurt your chances, including endometriosis, uterine polyps, uterine and diseased fallopian tubes. Pelvic adhesions can also restrict blood flow to the ovaries and interfere with normal development of eggs. Conducted before Cesare and other major features can often lead to adhesions, resulting in infertility. Numerous published studies have shown that minimally invasive, outpatient treatment by experienced surgeons perform hysteroscopy and laparoscopy will often increase fertility or to prevent infertility.

“Most women have abortions because of these problems, many IVF centers tend to be drawn from this information,” said Barbara A. McGuirk, MD, a reproductive endocrinologist and director of reproductive surgery RAD is a program since 1995. “When we do a detailed and thorough evaluation of the uterus, ovaries, fallopian tubes and pelvic structures to the present time, and treating diseases that cause infertility. Our approach includes professional 2-doc team, excellent anesthesia and surgery performed through a small opening in the skin that does not rate. “

Centers for Disease Control (CDC), there are many cases of female infertility “unexplained”. “Unexplained infertility in women is often unknown infertility,” said Dr. McGuirk, “and we believe that many women and children are shortchanged and premature damage to continue IVF treatment. Many of our patients who may have been pushed into IVF else actually able to for pregnancy at our center without IVF. “

work team is expected to fit in the pilot program will help assess the extent of the problem associated with unsuccessful IVF treatment and unnecessary. Their goal is to find patients who have been unsuccessful with IVF and non-RAD and had pre-existing conditions or to evaluate carefully treated. RAD team is particularly interested in the assessment of women before or after fertilization, which are marked with “unexplained infertility”.

IVF results are presented and are issued by most U.S. clinics in collaboration with the CDC to the public to read. “Some of the CDC data misleading,” said Dr. Feinberg, “because it is very difficult to know what patients really need IVF compared to those who could benefit from non-IVF treatments. Patients who achieved a pregnancy after hysteroscopy and / or laparoscopy not included in the CDC data. “

of all IVF pregnancies achieved in Delaware, was 85% conceived in the mid-RAD is based on an analysis of the published CDC data. Many of these results and lower risk singleton pregnancy was directed to the appropriate models of care, resulting in work, including many patients who have failed IVF elsewhere. As more evidence of increased embryo in the womb an embryo is a blastocyst transfer RAD approach has consistently delivered many pregnant women, and one of the lowest Multiple pregnancy rates in the U.S.

RAD Group is also actively evaluating chromosomal abnormalities in the blastocysts that appear normal but are likely to lead to failed implantation or miscarriage. Performance and results of preimplantation genetic screening (PGS), are presented at national meetings in 2010 and 2011, American Society for Reproductive Medicine (ASRM).

Doctor RAD team has two other reproductive endocrinologists Dr. Adrienne Neithardt and Dr. George Kovalevsky and four doctors to advise patients on the three different locations in Wilmington Delaware, Dover, and the main office and IVF Center in Newark on the campus of Christiana Health System . Doctors also meet doctors and teachers work for Christiana Care obstetrics / gynecology residents and medical students to Jefferson.

###

New York Center for Human Reproduction (CHR) is pleased to announce that the U.S. Patent and Trademark Office has accepted a patent application for the treatment of infertility, serial number 8067400, titled androgen receptor therapy in women.

requirements of this permit application – the latter is based on research Chrs dehydroepiandrosterone (DHEA) in women with infertility – focused on methods to reduce the rate of aneuploidy (chromosomal abnormalities) in human embryos, decreases during pregnancy and improve pregnancy rates by androgens given for at least two months.

, it means that DHEA has been approved (in the second patent issued CHR) infertility treatment to increase pregnancy, reduce the time of conception and reduction of chromosomal abnormalities in embryos. DHEA is the first agent ever approved to reduce chromosomal abnormalities in human embryos. Since about 85% of all human thought that abortion due to chromosomal abnormalities, DHEA can be expected to reduce abortion rates.

CHR investigators noticed a reduction in the risk of miscarriage after DHEA supplement [Gleicher et al, abortion rates of dehydroepiandrosterone (DHEA) replacement therapy in women with reduced ovarian reserve. case control study. Reprod Biol Endocrinol 2009;. 7:108]

second patent CHR only confirms the growing importance of DHEA in female infertility, in addition, we had the opportunity to follow our research for more than seven years, notes Norbert Gleicher, MD, Medical Director and Founder of Chrs, and one of the inventors listed in the DHEA the patent. He suggests that the further approval of the claim that DHEA reduces chromosomal abnormalities in the embryo provides an excellent opportunity, because this research suggests that DHEA supplement May benefit not only women with infertility.

picking up on that thought, David H. Barad, MD – Clinical Director Chrs IVF and other inventors listed on patents – evidence of chromosomal abnormalities in embryos increases as women age. Therefore, abortion is increased in parallel. DHEA supplements may also be useful in older women with normal fertility trying to conceive on their own. “It adds to the birth of a multivitamin in the future may also contain DHEA.

Center for Human Reproduction (http://www.centerforhumanreprod.com) is a leading infertility center in New York with global customers, known for large clinical trials program. The program is a series of important breakthroughs in the IVF procedure. Dr. Gleicher is available for further comment.

###